mother and daughter holding hands laughing

We're Visionaries, Driven by Our Humanity

Pushing the Boundaries of Science and Care Solutions

Our passionate team of thinkers is working to alleviate the burdens of those affected by central nervous system (CNS) conditions.

Creating a Roadmap for Innovation
Learn More

We’re always looking forward to the next step: Delivering hope through tangible solutions for patients suffering from central nervous system (CNS) conditions.

Learn More
Hispanic man in a wheelchair with someone's hand on his shoulder
Who We Are

Every day, we bring a singular focus to the research and development of groundbreaking pharmaceutical treatments for people with CNS conditions.

Read More
Leadership Team
We have a passion for patients, based on our own personal experiences. When combined with scientific ingenuity and a commitment to transparency, we offer real solutions to those we serve.
Learn More
Governance & Transparency
To truly serve patients, we must conduct our business with honesty and integrity. This extends to our governance teams, where ethical behavior and accurate reporting is required.
Learn More
Working at Avanir
Become part of a diverse group of dedicated professionals at the forefront of developing treatments for CNS conditions in areas of unmet need, while honoring a high standard of integrity.
Learn More
Working at Avanir
View Opportunities

Become part of a diverse group of dedicated professionals at the forefront of developing treatments for CNS conditions in areas of unmet need while honoring a high standard for integrity.

View Opportunities
Funding & Support
As part of our commitment to improving patient care, we offer funding to healthcare providers and other stakeholders to advance the field of CNS conditions.
Learn More
Patient Assistance
We believe that all patients should have access to the revolutionary CNS treatment we've developed — regardless of their financial situation.
Learn More
Clinical Trials
This vital step helps us answer questions about a particular disease, test the safety and effectiveness of a treatment or evaluate new uses.
Learn More

MLR-AVN-US-0388-0420